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We describe a role for diacylglycerol in the activation of Ras
and Rap1 at the phagosomal membrane. During phagocytosis,
Ras density was similar on the surface and invaginating areas of
the membrane, but activation was detectable only in the latter
and in sealed phagosomes. Ras activation was associated with
the recruitment of RasGRP3, a diacylglycerol-dependent Ras/
Rap1 exchange factor. Recruitment to phagosomes of RasGRP3,
which contains a C1 domain, parallels and appears to be due to
the formation of diacylglycerol. Accordingly, Ras and Rap1 acti-
vation was precluded by antagonists of phospholipase C and of
diacylglycerol binding. Ras is dispensable for phagocytosis but
controls activation of extracellular signal-regulated kinase,
which is partially impeded by diacylglycerol inhibitors. By con-
trast, cross-activation of complement receptors by stimulation
of Fc receptors requires Rap1 and involves diacylglycerol. We
suggest a role for diacylglycerol-dependent exchange factors in
the activation of Ras and Rap1, which govern distinct processes
induced by Fc receptor-mediated phagocytosis to enhance the
innate immune response.
Receptors that interact with the constant region of IgG
(FcR)4 mediate the recognition and elimination of soluble
immune complexes and particles coated (opsonized) with
immunoglobulins. Clustering of FcR on the surface of leuko-
cytes upon attachment to multivalent ligands induces their
activation and subsequent internalization. Soluble immune
complexes are internalized by endocytosis, a clathrin- and
ubiquitylation-dependent process (1). In contrast, large, partic-
ulate complexes like IgG-coated pathogens are ingested by
phagocytosis, a process that is contingent on extensive actin
polymerization that drives the extension of pseudopods (2). In
parallel with the internalization of the opsonized targets, cross-
linking of phagocytic receptors triggers a variety of other
responses that are essential components of the innate immune
response. These include degranulation, activation of the respi-
ratory burst, and the synthesis and release of multiple inflam-
matory agents (3, 4).
Like T and B cell receptors, FcR possesses an immunore-
ceptor tyrosine-based activation motif that is critical for signal
transduction (3, 4). Upon receptor clustering, tyrosyl residues
of the immunoreceptor tyrosine-based activation motif are
phosphorylated by Src family kinases, thereby generating a
docking site for Syk, a tyrosine kinase of the ZAP70 family (3, 4).
The recruitment and activation of Syk in turn initiates a cascade
of events that include activation of Tec family kinases, Rho- and
ARF-family GTPases, phosphatidylinositol 3-kinase, phospho-
lipase C (PLC), and a multitude of additional effectors that
together remodel the underlying cytoskeleton, culminating in
internalization of the bound particle (5, 6).
Phosphoinositide metabolism is thought to be critical for
FcR-induced phagocytosis (7, 8). Highly localized and very
dynamic phosphoinositide changes have been observed at
sites of phagocytosis: phosphatidylinositol 4,5-bisphosphate
(PtdIns(4,5)P2) undergoes a transient accumulation at the
phagocytic cup, which is rapidly superseded by its complete
elimination from the nascent phagosome (7). The secondary
disappearance of PtdIns(4,5)P2 is attributable in part to the
localized generation of phosphatidylinositol 3,4,5-trisphos-
phate, which has been reported to accumulate at sites of phag-
ocytosis (9). Activation of PLC is also believed to contribute to
the acute disappearance of PtdIns(4,5)P2 in nascent phago-
somes. Indeed, the generation of diacylglycerol (DAG) and ino-
sitol 1,4,5-trisphosphate has been detected by chemical means
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during FcR-evoked particle ingestion (10, 11). Moreover,
imaging experiments revealed that DAG appears at the time
and at the precise site where PtdIns(4,5)P2 is consumed (7).
Two lines of evidence suggest that the DAG generated upon
engagement of phagocytic receptorsmodulates particle engulf-
ment. First, antagonists of PLC severely impair phagocytosis by
macrophages (7, 12). This inhibition is not mimicked by pre-
venting the associated [Ca2] transient, suggesting that DAG,
and not inositol 1,4,5-trisphosphate, is the crucial product of
the PLC (13). Second, the addition of exogenous DAG or phor-
bol esters, which mimic the actions of endogenous DAG, aug-
ment phagocytosis (14, 15).
Selective recognition of DAG by cellular ligands is generally
mediated by specific regions of its target proteins, called C1
domains (16). Proteins bearing C1 domains include,most nota-
bly, members of the classical and novel families of protein
kinaseC (PKC),making them suitable candidates to account for
the DAG dependence of phagocytosis. Indeed, PKC, a classi-
cal isoform, and PKC and PKC, both novel isoforms, are
recruited to phagosomes (12, 15, 17, 18). Although the role of
the various PKC isoforms in particle engulfment has been
equivocal over the years, Cheeseman et al. (12) convincingly
demonstrated that PKC contributes to particle uptake in a
PLC- and DAG-dependent manner.
PKCs are not the sole proteins bearing DAG-binding C1
domains. Similar domains are also found in several other pro-
teins, including members of the RasGRP family, chimaerins,
and Munc-13 (19–21). One or more of these could contribute
to the complex set of responses elicited by FcR-induced DAG
production. The RasGRP proteins are a class of exchange fac-
tors for the Ras/Rap family of GTPases (22). There are four
RasGRP proteins (RasGRP1 to -4), and emerging evidence has
implicated RasGRP1 and RasGRP3 in T and B cell receptor
signaling (23–27).
The possible role ofDAG-mediated signaling pathways other
than PKC in phagocytosis and the subsequent inflammatory
response has not been explored. Here, we provide evidence that
DAG stimulates Ras and Rap1 at sites of phagocytosis, probably
throughRasGRPs. Last, the functional consequences of Ras and
Rap1 activation were analyzed.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies—Human IgG and glutathione-aga-
rose beads were from Sigma. PMA, calphostin C, GF109203X,
andU73122were fromCalbiochem or Biomol. Latex beads (2.0
and 3.1 m in diameter) were from Bangs Laboratories. Sheep
red blood cells and rabbit anti-sheep red blood cell antibodies
were from ICN/Cappel. Anti-sheep red blood cell (RBC) IgM
was from Accurate Chemicals. Murine monoclonal antibodies
to H-Ras (F235), N-Ras (F155), and RasGRP (199) and rabbit
antibodies to K-Ras (C-19) were from Santa Cruz Biotechnol-
ogy, Inc. (Santa Cruz, CA). Monoclonal anti--tubulin (B125)
was from Sigma.Murinemonoclonal H/N-Ras antibodies were
fromViromed Biosafety Laboratories. Rabbit antibody to phos-
pho-ERK1/2 (Thr202/Tyr204) was from Cell Signaling. Rat
monoclonal anti-mouse LAMP1 (1D4B)was from theDevelop-
mental Studies Hybridoma Bank (Iowa City, IA). Mouse
anti-T7 antibody was from Novagen. Rabbit anti-RasGRP3
antibodies were previously characterized (26). Polyclonal Rap1
antibodies were from Santa Cruz Biotechnology (Krev-1). Flu-
orescent or peroxidase-coupled secondary antibodies were
from Jackson Laboratories, Pierce, and Molecular Probes.
Cell Culture,DNAConstructs, andTransfection—RAW264.7
macrophages obtained from ATCC were maintained in Dul-
becco’s modified Eagle’s medium supplemented with 10% fetal
calf serum at 5% CO2 at 37 °C. The generation of Rat2 cells
stably expressing RasGRP3 was previously described in Ref. 28.
Constructs encoding the untagged dominant negative
mutant of H-Ras and H-RasN17, GFP-H-RasN17, T7-tagged
N-Ras, and a bacterially expressed RasGTP-binding domain of
Raf1 (RBD) fused to GSTwere gifts fromDr. D. Rotin (Hospital
for Sick Children, Toronto, Canada). The generation of GFP-
H-Ras, GFP-N-Ras, and GFP-K-Ras, which encode GFP fusion
proteins of H-Ras, N-Ras, and K-Ras, respectively, was
described in Ref. 29. Construction of the RBD fused to GFPwas
previously described in Ref. 30. Transfections were accom-
plished using FuGene 6 (Roche Applied Science) according to
the manufacturer’s instructions. The Rap1 GTP binding
domain of Ral-GDS fused to GST (GST-RalGDS) was gener-
ated as described (31).
Reverse Transcription-Polymerase Chain Reaction (RT-PCR)—
RT-PCR was employed to detect mRNA expression of Ras-
GRP1, RasGRP2, andRasGRP3 inRAW264.7macrophages and
murine brain extracts using the Titan RT-PCR kit (Roche
Applied Science), as instructed by the manufacturer. mRNA
from RAWmacrophages and tissue extracts was isolated using
the mRNA isolation kit from Roche Applied Science. To
amplify RasGRP1, we used two primer sets; amplification of the
5 region encompassing nucleotides 38–764 was with GRP1U
(5-AGGCTCCGCGGAAACCTTGCCAT-3) and GRP1D
(5-CACAGGGCAATGGACCTCTCCATG-3), whereas the
3 region encompassing nucleotides 841–1310waswithGRP1–
841 (5-AAGTTCATCCATGTGGCTCAGAAAC-3) and
GRP1–1310 (5-CGGGCATAGGAAAGCTCATAGATTTC-
3). Nucleotides 20–646 of RasGRP2 were amplified using
GRP2U (5-CTGGTTCAAGTGAACAGAAGGTCTGG-3)
and GRP2D (5-GTTCTGCCAGTTCCATAGGCTCCAAG-
3). The region of RasGRP3 encompassing nucleotides 345–
694 was amplified using GRP3U (5-TTCCTTCTTATGACT-
GGATGAGG-3) and GRP3 (5-GGGCTACATTGATGAAC-
TTTGTG-3). Amplification of the N-Ras region 250–752
served as a positive control and was performed using the prim-
ers NRasU (5-AGGTGGTGTTGGGAAAAGCGCCCT-3)
and NRasD (5-GAGTGCCATCGTCACTGCTGTTGAG-3).
Phagocytosis Assay—Sheep RBCs were opsonized for 1 h
using a 1:50 dilution of rabbit anti-sheep RBCs. Latex beads
were similarly opsonized using 1 mg/ml human IgG. Phago-
cytic targets were then washed three times with phosphate-
buffered saline. To quantify the phagocytic index in cells
expressing the Ras dominant negative allele, H-RasN17, phag-
ocytosis of RBCswas allowed to proceed for 15min, followed by
lysis of adherent extracellular RBCs with water and fixation
with 4% paraformaldehyde. Internalized RBCs were identified
by bright fieldmicroscopy and/or stainingwithCy3-conjugated
anti-rabbit antibodies. To determine phagosomematuration in
the presence of H-RasN17, cells were induced to internalize
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RBCs, and the phagosomes were allowed to mature for 60 min,
followed by fixation and immunostaining for LAMP1. C3bi
opsonization and binding assays were performed as described
previously (32).
Ras and Rap1 Activation Assay—Affinity precipitation of
Ras-GTP andRap1-GTPwas performed as described in Ref. 33.
Briefly, GST-RBD (for Ras-GTP) or GST-RalGDS (for Rap1-
GTP) was induced in the DH10 Escherichia coli strain using 1
mM isopropyl 1-thio--D-galactopyranoside for 3 h at 37 °C.
After expression andpelleting, bacteriawerewashed inHEPES-
buffered saline (20 mM HEPES, 150 mM NaCl, pH 7.4) and
resuspended in BLB buffer (20 mM HEPES, pH 7.5, 120 mM
NaCl, 10% glycerol, 2 mM EDTA, supplemented with a 1:100
dilution of prokaryotic anti-protease mixture). Bacteria were
then lysed by two “French press” passes, and the supernatant
was cleared by centrifugation. The lysate was supplemented
with 0.5% Nonidet P-40 and incubated with glutathione-agar-
ose beads for 30 min. The loaded beads were washed and used
to precipitate Ras-GTP or Rap1-GTP within 2 days.
To assay for phagocytosis-dependent activation of Ras or
Rap1, macrophages were incubated with opsonized RBCs on
ice for 20min and thenwarmed to 37 °C for the indicated times.
Phagocytosis was arrested by washing with cold phosphate-
buffered saline, and macrophage lysates were prepared by the
addition of cold MLB buffer (25 mM HEPES, pH 7.5, 150 mM
NaCl, 0.25% sodium deoxycholate, 10% glycerol, 1 mM EDTA,
and 10 mM MgCl2 added immediately before use) supple-
mented with a 1:100 dilution of eukaryotic protease inhibitor
mixture (Sigma). Cell lysates were then cleared by centrifuga-
tion, and the supernatant was incubated with freshly prepared
glutathione-agarose beads coupled to GST-RBD or GST-Ral-
GDS for 30min in the cold. The beads were washed three times
with 0.6 ml of MLB buffer, and bound Ras-GTP or Rap1-GTP
was then eluted by boiling in twice concentrated Laemmli
buffer. Samples were analyzed by SDS-PAGE, blotted onto
polyvinylidene difluoride, and subjected to quantitative immu-
noblotting analysis using monoclonal H/N-Ras antibodies
(1:20,000) or polyclonal Rap1 antibodies (1:500).
Immunoblotting—To detect expression of Ras and RasGRP
isoforms, RAW, Rat2, Rat2-GRP3 (engineered by retroviral
infection to express RasGRP3), and Jurkat cells were lysed in
Laemmli buffer. Brain and spleen lysates were prepared by
homogenizing tissue in aDounce homogenizer, followed by the
addition of Laemmli buffer and boiling. Lysates were then
cleared by centrifugation, and protein concentration was esti-
mated by spotting on Whatman paper and Coommassie Blue
staining, using bovine serum albumin as a standard. To detect
ERK1/2 activation, RAW cells were lysed in Laemmli buffer
immediately after the desired treatment. Twenty to forty
micrograms of protein were subjected to SDS-PAGE and trans-
ferred to a polyvinylidene difluoride membrane. Blots were
blockedwith 5%milk in phosphate-buffered saline orTris-buff-
ered saline. All primary and secondary antibodies were incu-
bated in 5% milk in phosphate-buffered saline, with the excep-
tion of phospho-ERK1/2 (Thr202/Tyr204) antibody, which was
in Tris-buffered saline. Rabbit antibodies to RasGRP3, K-Ras,
Rap1, and phospho-ERK1/2 were used at 1:250, 1:700, 1:500,
and 1:2500, respectively. Monoclonal antibodies to H-Ras,
N-Ras, RasGRP1, and tubulin were employed at 1:1000, 1:700,
1:500, and 1:5000, respectively. All horseradish peroxidase-
coupled secondary antibodies were used at a 1:5000 dilution.
Immunofluorescence and Confocal Imaging—For immuno-
fluorescence experiments, macrophages were fixed with 4%
paraformaldehyde, followed by permeabilizationwith 0.1%Tri-
ton and blockingwith 5% donkey serum.Untagged RasN17was
detected using mouse anti-H-Ras (Santa Cruz Biotechnology)
at 1:100, T7 epitope-tagged N-Ras was detected with a 1:1000
dilution of mouse anti-T7 antibodies, LAMP1 was detected
using undiluted rat anti-mouse LAMP1 supernatant, and
endogenous RasGRP3 was stained with a 1:100 dilution of rab-
bit anti-RasGRP3 antibodies. Staining with anti-phospho-
ERK1/2 antibodies was performed as instructed by the supplier
and using phosphatase inhibitors. All secondary antibodies
were used at 1:1000. Cells were observed with a Zeiss LSM510
scanning laser confocal microscope using the conventional
laser lines and filter sets. The method used to monitor fluores-
cence during the course of phagocytosis in live cells was
described (7).
RESULTS
Members of the RasGRP Family Are Expressed in Phagocytic
Cells—RAW264.7 cells (referred to hereafter as RAW cells)
were used for these studies. This murine line has been used
extensively for the biochemical andmolecular analysis of phag-
ocytosis, because it accurately recapitulates the phagocytic phe-
notype of monocytes/macrophages and because it is amenable
to transfection, albeit with modest efficiency (7, 9, 17). We first
analyzed whether RasGRP1, RasGRP2, and/or RasGRP3 are
expressed in RAW cells, using RT-PCR. RasGRP4 was not
investigated. In accordance with earlier reports, expression of
all three RasGRP species was confirmed in mRNA extracted
from murine brains, validating the adequacy of the primer sets
used (Fig. 1A). The quality of the mRNA extracted from RAW
cells was tested by the positive amplification of N-Ras, a widely
expressed protein (Fig. 1A, lane 5). As shown in Fig. 1A, mRNA
encoding for RasGRP1 andRasGRP3, but not for RasGRP2, was
detected in RAW cells (Fig. 1A).
Western blotting was utilized next to evaluate protein
expression of RasGRP1 and RasGRP3 (Fig. 1B). The mono-
clonal antibody m199 readily detected RasGRP1 in both spleen
and brain extracts from mice. However, the same titer of the
antibody failed to detect RasGRP1 in RAW cells. This probably
implies that the expression level of the protein is low in these
cells or, alternatively, that they express a unique splice variant
that is not identified by the antibody (see “Discussion”). The
suitability of the polyclonal antibody used to detect RasGRP3
was validated using extracts of Rat2 cells that were stably trans-
fected with the protein. Untransfected Rat2 cells, which do not
express RasGRP3, were used as negative control (Fig. 1B). As
shown in Fig. 1B, RasGRP3 was abundantly expressed in RAW
cells. We therefore concentrated our attention on this isoform
for the remainder of this study.
RasGRP3 Is Recruited to Phagocytic Cups—We had reported
earlier that DAG accumulates focally at sites of phagosome
generation (7). To investigate whether phagosomal DAG is
capable of recruiting and potentially activating RasGRP3,
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RAW macrophages were transfected with a plasmid encod-
ing GFP-tagged RasGRP3. The distribution of RasGRP3-
GFP in unstimulated cells was predominantly cytosolic (Fig.
2A), but the addition of a DAG-mimetic phorbol ester (100
nM PMA) induced translocation of a fraction of RasGRP3-
GFP to the plasma membrane (Fig. 2A). In a fraction of the
cells (15%), PMA caused RasGRP3-GFP to accumulate in a
juxtanuclear structure, probably the Golgi apparatus (not
shown).
The behavior of RasGRP3 during phagocytosis of IgG-opso-
nized RBCs was studied next. Little or no redistribution of Ras-
GRP3-GFP was observed at the earliest stages of phagocytosis
(e.g. arrow b in Fig. 2B, t  6.5, points to a phagocytic cup
formed within 30 s of RBC attachment to the surface of the
macrophage). However, at later stages of phagocytosis, when
pseudopod extension was prominent, and particularly when
RBC enclosure was completed, the accumulation of RasGRP3
was readily apparent in 50–70% of the phagosomes (e.g. arrow-
head a in Fig. 2B, t 1.25, points to an enclosed RBC), although
the extent of recruitment varied between phagocytic cups. Ras-
GRP3-GFP remained on the phagosomal membrane for 1–5
min following closure and then dissociated gradually (e.g.
arrowhead a in Fig. 2B, t 5). Association of endogenous Ras-
GRP3 with the phagosomal membrane was confirmed by
immunostaining with the polyclonal antibody described in the
legend to Fig. 1 (supplemental Fig. S1A). Although the latter
experiments lacked the dynamic information gathered with
RasGRP3-GFP, they indicated that the observed association is
not the artifactual result of heterologous (over)expression of
the exchange factor. Moreover, a yellow fluorescent protein-
tagged version of the RasGRP1 isoform expressed in brain was
not observed on phagocytic cups or phagosomes, indicating
that RasGRP3 is specifically recruited during phagocytosis
(supplemental Fig. S1B).
FIGURE 1. Expression of RasGRP isoforms in macrophages. A, detection
of RasGRP isoforms by RT-PCR using as template mRNA extracted from
murine brain (top) or from RAW macrophages. Lane 1, RasGRP1 using
primers encompassing nucleotides 38–764; lane 2, RasGRP1 using primers
encompassing nucleotides 841–1310; lane 3, RasGRP2; lane 4, RasGRP3;
lane 5, N-Ras; lane 6, molecular weight markers. The arrowhead and arrow
point to the predicted product and an unexpected 500-bp product,
respectively, amplified using primers encompassing nucleotides 38–764
of RasGRP1. B, detection of RasGRP isoforms by immunoblotting. The top
blot contains samples with equivalent protein loads of RAW cells and of
murine splenic and brain extracts and was probed with antibodies to Ras-
GRP1. The bottom blot contains samples with equivalent protein loads of
RAW cells, Rat2 cells, and Rat2 cells stably transfected with RasGRP3 that
were probed with antibodies to RasGRP3.
FIGURE 2.RasGRP3distributionduringphagocytosis.RAWcellswere tran-
siently transfected with RasGRP3-GFP and analyzed by confocal microscopy.
A, resting (untreated) and treated cells with 100 nM PMA for 15 min. B, cells
monitored during the engulfment of IgG-opsonized RBCs. The various panels
are a temporal series proceeding from left to right and from top tobottom. The
numbers indicate the time (min) after acquisition of the first image. Note that
RBCs had been added to the cells several min before acquisition of the first
image. The arrows indicate a phagocytic cup, and arrowheads point to sealed
phagosomes. Selected RBCs undergoing phagocytosis are labeled a–c. Scale
bar, 10 m.
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Ras Is Activated during Phagocytosis—The recruitment of
RasGRP3 to sites of phagocytosis suggested that Ras may be
activated during FcR-mediated phagocytosis, at least in part
by a DAG-dependent process. To test this hypothesis, we first
determinedwhich isoforms of Raswere expressed in RAWcells
by immunoblotting whole cell lysates. As illustrated in Fig. 3A,
N-Ras andK-Raswere clearly present in RAWmacrophages. In
contrast, H-Ras was not detected in either RAW cells, in other
leukocytes like Jurkat lymphocytes or inmurine spleen extracts,
but was observed in the brain, confirming the reactivity of the
antibody used (Fig. 3A). Therefore, N-Ras and K-Ras became
the focus of our subsequent studies in RAW cells.
We employed aGST fusion of RBD to assess the activation of
Ras during FcR-mediated phagocytosis. This GST-RBD
fusion protein selectively precipitates the activated form of Ras,
which was then quantified by immunoblotting (33). The effec-
tiveness of the method was initially confirmed by stimulating
the cells with PMA, a well established activator of Ras (26) (Fig.
3B). Twodifferent approacheswere used to analyze the effect of
Fc receptor activation on Ras. First, the receptors were cross-
linked with aggregated IgG to produce a global and synchro-
nous stimulation. This manipulation induced a marked activa-
tion of Ras (cf. stimulated lane with unstimulated control,
labeled 0 in Fig. 3B). Second, Fc receptors were activated
focally by exposure to IgG-opsonized RBCs.When the onset of
phagocytosis was synchronized by preincubating RAW cells
with the IgG-opsonized RBCs in the cold, a rapid and transient
activation of Ras was observed, which was detectable within 2
min, peaked after 5 min and was abated by 10 min (Fig. 3, B
and C). A similar transient activation of Ras had been reported
earlier following antibody-mediated cross-linking of Fc recep-
tors in U937 cells (34).
Distribution of N-Ras during Phagocytosis—Like Ras, small
GTPases of the Rho family are also activated during phagocy-
tosis (35). Rac and Cdc42, which are activated upon cross-link-
ing of FcR, accumulate at sites of phagocytosis (36). To analyze
whether Ras is also recruited to the phagocytic cup, we trans-
fected RAW cells with either GFP-tagged N-Ras or K-Ras con-
structs because the endogenous Ras isoforms were not detect-
able by immunostaining with available antibodies. Expression
of the fluorescent proteins also enabled us to perform dynamic
studies in living cells. As reported in other systems (37), GFP-
N-Raswas enriched in the plasmamembrane but was also pres-
ent in a juxtanuclear compartment, probably theGolgi complex
(Fig. 4A). GFP-K-Ras was similarly found in the plasmalemma
with a small fraction in diffuse vesicular structures, possibly
endosomes (38, 39) (see Ref. 40 for illustration). Expression of
the GFP-tagged proteins had no discernible effect on the kinet-
ics or efficiency of phagocytosis. Neither N-Ras (Fig. 4A) nor
K-Ras (not shown; see Ref. 40) displayed a propensity to accu-
mulate in phagocytic cups, compared with their density in
unengaged regions of the surface membrane. Notably, GFP-N-
Ras remained associated with the phagosomes for at least 20
min, although N-Ras activation is largely terminated after 10
min. By comparison, GFP-K-Ras was depleted from the phago-
somal membrane following RBC engulfment, an effect attrib-
uted recently to changes in the surface charge of themembrane
upon phagocytosis (40). These observations suggest that acti-
vation of Ras during phagocytosis does not involve its preferen-
tial recruitment to the nascent phagosome; nor is deactivation
dependent on its detachment from the phagosomalmembrane.
Localized Activation of Ras at the Phagocytic Cup—Because
RasGRP3 was recruited to the phagosomal cup, we hypothe-
sized that this leads to localized activation of K-Ras and N-Ras.
To this end, we used a GFP fusion protein of the Raf-1 RBD
domain (GFP-RBD), which was used successfully to probe the
subcellular dynamics of RasGTP (30). RAW cells were
co-transfected with GFP-RBD and N-Ras. Overexpression of
Ras was required, since the endogenous levels of RasGTP were
insufficient for detection by this method, as seen in other sys-
tems (30). As shown in Fig. 4B, in unstimulated cells, GFP-RBD
was mostly cytosolic, with no obvious association with the
plasma membrane. Treatment of cells with 100 nM PMA
induced migration of GFP-RBD to a juxtanuclear location,
probably theGolgi complex, and to a lesser extent to the plasma
membrane (Fig. 4B).
The distribution of GFP-RBD was next studied during the
course of phagocytosis. Most frequently, little or no accumula-
tion of RasGTP was detectable at the earliest stages of phago-
FIGURE 3. Expression of endogenous Ras isoforms in macrophages and
activation during phagocytosis. A, detection of Ras isoforms by immuno-
blotting. Blots contain samples with equivalent protein loads of RAW and
Jurkat cells and of murine splenic and brain extracts and were probed with
antibodies to H-Ras, K-Ras, and N-Ras (from top to bottom, as indicated). The
arrows point to Ras. B, Ras activation in RAW cells was assessed using the
RBD-GST pull-down assay described under “Experimental Procedures.” As a
control, beads coated with only GST were mixed with activated lysate (GST).
The lane labeled W is a fraction of whole cell lysate. Samples were stimulated
by PMA (100 nM) by the addition of aggregated IgG (AIg) to simultaneously
stimulate all FcR or by exposure to IgG-coated RBCs (Phagocytosis) for the
indicated time (min).C, quantificationof the courseof activationof Rasduring
phagocytosis, from four experiments like that illustrated in B. Quantification
was performed by densitometry of scanned films using Image J software. To
enable comparison between experiments, all values were normalized to the
intensity of the unstimulated (t 0) cells. Data are means S.E.
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somal cup formation (e.g. arrow b in Fig. 4C, t  0 and 1 min;
arrow c, t 2.75min; and arrow d, t 4min). By contrast, focal
accumulation of GFP-RBD was discernible on the advancing
pseudopods when they had nearly surrounded the RBCs (e.g.
arrow b in Fig. 4C, t  1.5 min). However, the formation of
RasGTP was most obvious on the membrane of the phago-
somes immediately after closure (e.g. arrowhead a in Fig. 4C,
t 0min and t 1min; arrow b, t 2.75min; and arrowheads
c and d, t 6 and 7min). Activated Raswas detectable on newly
formed phagosomes for 4–12min after sealing (e.g. arrowheads
in Fig. 4C, t 9 min), waning thereafter. This transient pattern
of RasGTP accumulation on the phagosomal membrane paral-
lels the kinetics of Ras activation determined by biochemical
means following synchronized phagocytosis by a population of
macrophages (Fig. 3C). These observations suggest that the Ras
activation detected in the cell lysates originated largely from the
phagosomal membrane. They also confirm the notion that
intracellular organelles, such as the Golgi complex, the endo-
plasmic reticulum (30), and, in our case, the phagosome, can
serve as platforms for focal Ras signaling.
Contribution of DAG to the Activation of Ras—Taken
together, the results presented above imply that RasGRP3 plays
a role in the activation of Ras at the phagosomalmembrane.Not
only is the exchange factor probably recruited to the nascent
phagosomes by the local generation of DAG, but the course of
recruitment of RasGRP3 parallels the formation of RasGTP on
the phagocytic vacuole (cf. Figs. 2 and 4). However, Ras is acti-
vated by a variety of exchange factors, some of which may also
be stimulated by phagocytic receptors (see “Discussion”). We
therefore performed studies to evaluate the contribution of
DAGandRasGRP3 to the observed stimulation.We first exam-
ined the sensitivity of Ras activation to the PLC antagonist,
U73122, which was previously shown to effectively inhibit PLC
activity inmacrophages (7). As illustrated in Fig. 5A, the activa-
tion of Ras normally seen in otherwise untreated cells perform-
ing phagocytosis was eliminated by pretreatment of the cells
with 5 or 10 M U73122. In addition, calphostin C, which
impairs binding of DAG to its protein effectors (21), also pre-
cluded Ras activation during phagocytosis (Fig. 5A). It is
unlikely that calphostin C produced this effect by interfering
with the binding of DAG to classical or novel PKC isoforms,
since the addition of GF109203X, a general antagonist of PKC
activity, did not affect Ras stimulation during ingestion (Fig.
5A). Thus, Ras stimulation was suppressed not only when the
formation of DAG was prevented by inhibition of PLC but also
when the interaction of DAG with its target molecules was
FIGURE 4.Dynamics of Ras andRas-GTPduringphagocytosis.A, RAWcells
were transiently transfectedwith a GFP fusion protein of N-Ras. Phagocytosis
was initiated by exposure of the transfected cells to IgG-opsonized RBCs.
Fluorescence was analyzed by confocal laser microscopy. The numbers indi-
cate the time (min) after acquisition of the first image. Note that RBCs had
been added to the cells before acquisition of the first image. Images are rep-
resentative of five experiments. B and C, RAW macrophages were co-trans-
fected with GFP-RBD and T7-N-Ras and analyzed by laser confocal micros-
copy. B, resting (untreated) and cells treated with 100 nM PMA; C, cells
monitored during the engulfment of IgG-opsonized RBCs. The various panels
are a temporal series proceeding from left to right and top to bottom. The
numbers indicate the time (min) after acquisition of the first image. Note that
RBCs had been added to the cells several min before acquisition of the first
image. The arrows point to phagocytic cups, and the arrowheads point to
sealed phagosomes. Selected RBCs undergoing phagocytosis are labeled
a–d. Scale bar, 10 m.
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impaired. RasGRP3, one such DAG effector, is most likely
involved in Ras stimulation.
Investigation of Ras Signaling in Phagocytosis and Phagosome
Maturation—Activation of Ras upon FcR activation sug-
gested that the GTPasemay contribute to signaling phagocyto-
sis. We therefore tested if signals emanating from active Ras
were required for phagosome formation ormaturation in RAW
cells, by expressing an untagged dominant negative allele,
H-RasN17. Expression of RasN17 was confirmed by immuno-
staining with anti-H-Ras. We employed H-RasN17 because it
was previously shown to impede signaling from all three Ras
isoforms, unlike N-RasN17 and K-RasN17, which specifically
inhibit N-Ras or K-Ras, respectively (41). We monitored and
compared the phagocytic index of control cells that did not
express H-RasN17 and of cells expressing the Ras dominant
negative construct. We found that H-RasN17 expression had
no discernible effect on the ability of RAW cells to engulf IgG-
opsonized RBCs (Fig. 5B). We next investigated whether inhi-
bition of Ras altered the ability of formed phagosomes to
mature. Maturation was assessed by the acquisition of the late
endosome/lysosome marker LAMP-1 (Fig. 5C). As with phag-
ocytosis, expression of RasN17 was without effect on the ability
of phagosomes to acquire LAMP-1. Together, these results sug-
gest that Ras does not directly regulate phagocytosis or phago-
some maturation.
ERK Activation during Phagocytosis Requires Ras and DAG-
mediated Signaling—Engagement of FcRs elicits an inflam-
matory response consisting of induction of expression and
secretion of cytokines, such as TNF and IL-1 (42, 43). Expres-
sion of TNF in leukocytes was shown to depend on FcR-
induced activation of the mitogen-activated protein kinases,
ERK1 and -2 (42, 43). Because these kinases can be activated by
Raf, a downstream effector of Ras, we examined whether Ras
and diacylglycerol-dependent signaling influence ERK activity
during phagocytosis.
We first investigated whether Ras was required for ERK acti-
vation during phagocytosis by immunostaining cells with an
antibody that detects ERK phosphorylated at positions Thr202/
Tyr204 (pERK). To this end, cells were transfected with GFP-H-
RasN17, and the transfectants were identified by their fluores-
cence. In unstimulated cells, pERK was perceptible near
background levels, whether or not cells expressed H-RasN17
(Fig. 6A, top). In contrast, the addition of aggregated IgG to cells
elicited phosphorylation of the ERK proteins (Fig. 6A, untrans-
fected cells).Of note, the presence ofH-RasN17 in cells severely
curtailed the formation of pERK following stimulation with
aggregated IgG (Fig. 6A, transfected cells in the lower panels).
Quantification of experiments like those in Figs. 6A indicated
that H-RasN17 significantly inhibited pERK formation in cells
activated by aggregated IgG (Fig. 6B).
We next used immunoblotting to study whether DAG was
needed for ERK activation. Whole cell lysates of cells treated
under the indicated conditions were blotted with antibodies to
pERK and tubulin, the latter used to normalize the pERK signal.
Results from three such experiments were quantified, and the
results are summarized in Fig. 6C. As observed by immunoflu-
orescence, FcR-mediated phagocytosis triggered phosphoryl-
ation of ERK (Fig. 6C). Importantly, preventing DAG synthesis
by treatment with the PLC antagonist, U73122, decreased
pERK levels. This effect was not due to impairment of PKC
activation, since inhibition of this family of kinases with
GF109203X in fact exaggerated the stimulation of ERK
observed during phagocytosis (Fig. 6C). Together, these find-
ings implicate the DAG-Ras signaling axis in the regulation of
ERK1/2 activity elicited by FcR engagement.
Rap1 GTPase Is Activated by Diacylglycerol and Modulates
Cross-activation of the Complement Receptor CR3 by Fc
Receptors—In addition to activating Ras, RasGRP3 also serves
as an exchange factor for Rap1 (22), anothermember of the Ras
superfamily ofGTPases. Rap1 regulates phagocytosis inDictyo-
FIGURE 5. Diacylglycerol-dependent activation of Ras and its involve-
ment in phagosome formation andmaturation.A, diacylglycerol-depend-
ent Ras activation in RAW cells. Ras activationwas probed using the RBD-GST
pull-down assay described under “Experimental Procedures” and in the leg-
end to Fig. 3. Cells were either unstimulated (Uns) or allowed to undergo
phagocytosis of IgG-coated RBCs. Additionally, cells undergoing phagocyto-
siswereeitheruntreated (Ct), pre-exposed to5M (U7_5) or 10M (U7_10,U7)
U73122 for 20min, or pretreated for 30min with 0.5M calphostin C (CaC) or
10 M GF109203X (GFX). Phagocytosis was allowed to proceed for 5–7 min
prior to cell lysis. Blots are representative of four similar experiments. B, quan-
tificationof phagocytosis in control cells and in cells expressing thedominant
negative alleleH-RasN17. Thephagocytic index (thenumberof RBCs internal-
ized/100macrophages) was calculated in three similar experiments. Data are
means  S.E. C, cells expressing H-RasN17 were allowed to internalize IgG-
coated RBCs and chased for 1 h. Cells were fixed and stained for LAMP-1 to
verify phagosomematuration. The inset shows internalized IgG-coated RBCs.
Scale bar, 10 m.
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stelium (44) and is required for complement receptor-mediated
phagocytosis (45). We previously demonstrated that engage-
ment of FcR cross-activates the complement receptor, CR3, a
member of the integrin family, enabling cells to recognize and
bind complement-opsonized particles (32). Moreover, this
cross-activation requires a DAG-dependent signaling pathway
(32). Therefore, we speculated that Rap1 may control FcR-
mediated cross-activation of CR3 receptors in a DAG-depend-
ent manner.
To test this hypothesis, we measured Rap1 activation by
affinity precipitation with a GST fusion of the Rap1/GTP-bind-
ing domain of RalGDS (Fig. 7A). As expected, PMA, a DAG-
mimetic compound, strongly stimulated Rap1 activation. Sim-
ilarly, FcR-mediated phagocytosis of IgG-opsonized RBCs
promoted Rap1 activation (Fig. 7A). Importantly, the PLC
inhibitor U73122 and the DAG antagonist, calphostin C,
potently blocked Rap1 stimulation after Fc receptor engage-
ment (Fig. 7, A and B). Data of three similar experiments are
quantified in Fig. 7B. Together, the data suggest that Rap1 acti-
vation during FcR-mediated phagocytosis requires DAG.
We then tested whether Rap1 played a direct role in the
cross-activation of CR3 receptors induced by FcR clustering.
To this effect, we cross-linked FcRs with aggregated IgG and
followed the ability of cells to adhere to complement-opsonized
sheep RBCs in the presence or absence of a dominant negative
allele of Rap1 (Fig. 7C). Notably, we found a striking inhibitory
effect in cells that expressed the dominant negative Rap1.
Although cells that expressed only the endogenous Rap1 bound
on average 4.4  0.2 complement-opsonized RBCs/cell, mac-
rophages expressing dominant negative Rap1 bound only 1.3
0.6 complement-opsonized RBCs/cell (Fig. 7C). This result
strongly suggests that Rap1 plays an integral role in the cross-
activation of complement receptors during FcR engagement
(Fig. 8).
DISCUSSION
RasGRPswere initially identified in neuronal tissues (46), but
members of this family of Ras nucleotide exchange factors were
subsequently shown to be expressed and functionally relevant
in immune cells (23, 25, 26, 47). Indeed, interference with DAG
metabolism in T cells alters Ras signaling, presumably by mod-
ulation of RasGRP activity (48, 49).Moreover, ablation of genes
encoding members of the RasGRP family results in abnormal
lymphocyte development and function and impaired activation
of the Ras-ERK signaling axis following stimulation of immune
receptors (24, 23, 49).
The experiments described here indicate that RasGRP
exchangers are also expressed in macrophages and are impor-
tant during the course of the innate immune response. Ras-
GRP1 and -3 were identified in RAWcells by RT-PCR, but only
RasGRP3was detectable by immunoblotting. Thismay indicate
that the translation of RasGRP1 is inefficient or that the protein
is not stable. However, it is conceivable that macrophages
express a splice variant that does not contain the epitope rec-
ognized by the monoclonal antibody used. In accordance with
this interpretation, we found that two separate products were
amplified when using brain mRNA and primers encompassing
nucleotides 38–764 of RasGRP1. The larger of these products
FIGURE 6. The role of Ras and DAG in ERK activation during phagocy-
tosis. A, RAW cells were transfected with GFP-H-RasN17 and immuno-
stained for pERK after the indicated treatments. In the top panels, cells
were untreated. In the bottom panels, cells were treated with 10 mg/ml
aggregated IgG (AggIgG) for 10 min. The dashed lines outline cells. Cells
transfected with GFP-H-RasN17 are denoted by a T, whereas those that
remained untransfected are indicated with a U. Scale bar, 10 m. B, quan-
tification of pERK fluorescence using ImageJ, from experiments like those
in A. To facilitate comparison, the signal was normalized to unstimulated,
untransfected cells. Data are means of three experiments, and S.E. is
shown. C, quantification of ERK1/2 phosphorylation by immunoblotting in
unstimulated cells (Uns) and in cells exposed to IgG-opsonized RBCs for 10
min (Phagocytosis). Cells undergoing phagocytosis were untreated (Ct) or
had been pretreated with U73122 (U7) or GF109203X (GFX). The pERK
content of the cells was determined as described under “Experimental
Procedures” and is normalized to that of control phagocytosis (Ct). Equal
loading was ensured or corrected for by stripping the blots and probing
for cellular tubulin. Data are means  S.E. of six experiments.
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was predicted on the basis of the published sequence, but the
smaller onewas unexpected.Of note, only the latter was detect-
able in RAW cells. The smaller product is unlikely to be an
artifact, since RasGRP1 was clearly detected in both brain and
RAWcells when using a different primer set (Fig. 1). Therefore,
the expression of RasGRP1 in macrophages remains uncertain,
and the possible existence of splice variants of this protein
needs to be explored in more detail.
Ras is activated in cells stimulated by IgG-opsonized parti-
cles, at least in part, by a DAG-mediated process that does not
appear to depend on PKC (Fig. 8). Three important findings
indicate that RasGRP3 contributes to this response. First, this
exchange factor is abundantly expressed in macrophages (Fig.
1) andwas found to associate with nascent phagosomes (Fig. 2).
Second, RasGRP3 recruitment coincided with the stimulation
of Ras. Third, Ras stimulation was abrogated by DAG antago-
nists, which presumably prevented DAG binding to the C1
domain of RasGRP3 (Fig. 5A). Our results suggest that Ras-
GRP3 may activate Ras independently of PKC signaling during
FcR-mediated phagocytosis in macrophages. This is in con-
trast to evidence suggesting that PKC-mediated phosphoryla-
tion of RasGRP3 is required for full activation in B cells (50, 51).
Possibly, non-PKC protein kinases can activate RasGRP3 in
RAW cells during phagocytosis.
It is important to note that although our results implicate
RasGRP3 in the activation of Ras, they do not exclude other
stimulatory pathways. To the extent that FcR signaling is ini-
tiated by tyrosine phosphorylation, one might anticipate that
the canonical SOS pathway would contribute also to the acti-
vation of Ras during phagocytosis. In fact, we can readily detect
recruitment to forming phagosomes of Grb2 (supplemental
Fig. S2), an adaptor protein that links SOS with phosphoty-
rosine moieties of activated receptor complexes. We were
unable to express full-length SOS in macrophages, but a more
stable construct containing its catalytic domain was found to
associate with nascent phagosomes very weakly (supplemental
Fig. S2).Nevertheless, based on the involvement of SOS inTCR,
FIGURE 7.Role of DAG-activated Rap1 in cross-activation of complement
receptors.A, Rap1 activation in RAWcells. Activationwasprobedusing aGST
fusion of the Rap1-GTP-binding domain of Ral1 in a pull-down assay
described under “Experimental Procedures.” Cells were either unstimulated
(Control), treated with PMA, or allowed to undergo 5-min phagocytosis of
IgG-opsonized sheep RBCs either without (sRBC) or with treatment with
U73122 (U7) or calphostin C (CaC). Loading was controlled by immunoblot-
ting for total Rap1. B, quantification of Rap1 activation. Quantification was
performed by densitometry of scanned films using Image J software. To
enable comparison between experiments, all values were normalized to the
intensity of PMA-treated cells. Data are means  S.E. *, p  0.05 compared
with untreated cells undergoing phagocytosis using Student’s t test. C, Rap1
requirement for CR3 cross-activation by Fc receptors. Cells were transfected
withorwithoutdominantnegativeRap1 (DN-Rap1) andactivatedwithaggre-
gated IgG. Subsequently, the number of complement-opsonized RBCs
bound to the macrophages was quantified after 30 min, as described in Ref.
32. Data shown are means S.E. from three different experiments.
FIGURE 8. Amodel for DAG-dependent activation of Ras and Rap1. FcR
clustering induces activation of Src/Syk kinases, which triggers PLC and the
subsequent release of DAG. We envision the DAG-mediated signal ramifying
into the recruitment andactivationof PKCs andRasGRPs. StimulatedRasGRPs
then convert Ras and Rap1 to their active forms. In our model, Ras activation
is independent of PKC and modulates ERK activity and the subsequent
inflammatory response, although other signals may contribute to ERK regu-
lation. Rap1, in turn, governs cross-activation of complement and possibly
other receptors. However, since cross-activation requires PKC (32), it is
unclear whether Rap1 activation needs PKC or if PKC and Rap1 act as parallel
but complementary and indispensable activities in this cross-activation.
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BCR, and FcR signaling, SOS probably contributes also to the
localized stimulation of Ras during phagocytosis (Fig. 4C). A
similar co-activation of SOS and RasGRP is thought to occur in
TCR signaling (52, 53). In the case of FcR-mediated phagocy-
tosis by macrophages, however, the contribution of SOS
appears to be secondary, to the extent that the activation of Ras
was largely abrogated by DAG antagonists. Similarly, Ras/ERK
activation following BCR stimulation is also thought to occur
predominantly through RasGRP1/RasGRP3, rather than SOS
(25).
A predominant role for DAG and RasGRP3 is also consistent
with the observed kinetics of Ras activation. Accumulation of
RasGTPwas conspicuously absent at the earliest stages of pseu-
dopod formation and extension and was apparent only later,
becoming most obvious shortly after phagosome sealing. This
parallels closely the course of accumulation of DAG (7) and of
RasGRP3 on phagosomes but is distinct from the kinetics of
association anddetachment ofGrb2 and of the fragment of SOS
described above.
Useful information can also be derived comparing the time of
residence of Ras on phagosomes with the course of its activa-
tion. N-Ras remained associated with phagosomes for an
extended time (20min), which clearly exceeded the period of
association of the GFP-RBD probe, an index of RasGTP forma-
tion. Because the intrinsic GTPase activity of Ras is low, termi-
nation of the stimulatory signal alone cannot readily explain the
inactivation. Instead, these observations suggest that a RasGAP
is responsible for the elimination of RasGTP. In this context, it
is noteworthy that IgG-opsonized particles engage not only
activating FcRs but also the inhibitory isoform FcRIIB.
Cross-linking of these receptors induces the recruitment of
p62dok, a RasGAP-binding protein (54). The ensuing recruit-
ment of RasGAP could readily explain the observed rapid ter-
mination of Ras signaling, despite the continued presence of
N-Ras on the phagosomal membrane.
Particle internalization and phagosome maturation are
clearly independent of Ras. There is precedent for FcR-medi-
ated activation of signaling pathways that do not appear to con-
trol particle internalization. For example, activation of phos-
phatidylinositol 3-kinase and of ERK in monocytes (55, 56),
elevation of cytosolic [Ca2] in macrophages (57), and stimula-
tion of receptor ubiquitylation (1) are all well documented to
occur after FcR-receptor engagement but they are all dispen-
sable for phagocytosis itself. These findings are not necessarily
superfluous or paradoxical, because, in parallel with particle
engulfment, FcRs trigger an array of ancillary reactions. Nota-
ble among these are the respiratory burst, the generation of
nitric oxide, and the synthesis and secretion of a variety of
inflammatorymediators (3, 4). FcR engagement leads to ERK-
and/or NFB-dependent expression of inflammatory gene
products (42, 43, 55, 58). In this study, we found that FcR-
induced stimulation of ERK requires Ras and is in part depend-
ent on DAG signaling. Because ERK lies upstream of the path-
way leading to the activation of NFB and AP-1, which in turn
control the expression of tumor necrosis factor  and other
cytokines in myeloid cells (42, 43, 55, 58), we propose that the
activation of Ras by FcR is a component of the inflammatory
response. It will be of interest to determine whether Ras fails to
be activated by other types of phagocytic stimuli, such as com-
plement-opsonized particles, which are not inflammatory.
RasGRP3 increases the rate of nucleotide exchange not only
of Ras but also Rap GTPases (22). Rap proteins have been
detected in the endo/phagocytic compartment (59) and have
been shown to play a role in phagocytosis inDictyostelium (44).
In mammalian phagocytes, they may contribute to phagocyto-
sis by mediating the activation of integrins, as shown in lymph-
oid cells (60, 61). Indeed, stimulation of FcR in macrophages
activates the complement receptor CR3, an integrin, and this
response involves PLC (32). Strikingly, in cells stimulated by
IgG-opsonized RBCs, we detected activation of Rap1 by a proc-
ess that required PLC activity and DAG. Cross-stimulation of
CR3 integrins also involves PKC (32). This implies that either
Rap1 activation requires two different targets of DAG, namely
RasGRP3 and PKC, or that integrin stimulation is accom-
plished through two parallel DAG signals, one consisting of the
RasGRP3-Rap1 axis and the other involving PKC (Fig. 8).More-
over, one might have predicted that a dominant negative
mutant of Ras would also block activation of Rap1 by RasGRP3,
in as much as the dominant negative protein acts by sequester-
ing the exchange factor in an inactive complex. However,
H-RasN17 may only block RasGRP3 activation of Ras in mem-
brane microdomains that serve as Ras signaling platforms,
whereas the dominant negative Rap1 protein might selectively
block Rap1 signaling in Rap1-specific microdomains.
In summary, we provide evidence for the presence, activa-
tion, and functional role of RasGRPs, a family of DAG-depend-
ent exchange factors for Ras and Rap1, during FcR-mediated
signaling in macrophages. Because of their likely role in the
activation of gene transcription, RasGRP3 and other members
of the RasGRP familymay become a target for the development
of anti-inflammatory agents and for the design of strategies to
manage immune-mediated diseases like arthritis and lupus.
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